MK-8189

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for MK-8189, covering 2018-12-26 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008) [Phase 2]